Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol 2014;65:360-6: telomerase expression and stem cells: urologic epithelial perspective

Eur Urol. 2014 Jun;65(6):e85-6. doi: 10.1016/j.eururo.2014.02.030. Epub 2014 Feb 25.

¹ YCR Cancer Research Unit, Department of Biology, University of York, York, UK.
² Department of Urology, Castle Hill Hospital, Cottingham, UK; Hull York Medical School, University of Hull, Hull, UK.
³ YCR Cancer Research Unit, Department of Biology, University of York, York, UK; Hull York Medical School, University of Hull, Hull, UK. Electronic address: n.j.maitland@york.ac.uk.

No abstract available

Publication types